Skip to main content
logo
Biovica International AB (publ) (STO:BIOVIC.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.3630
-0.0070 (-1.89%)
Jul 3, 2026, 3:54 PM CET

Biovica International AB Revenue

In the fiscal year ending April 30, 2026, Biovica International AB had annual revenue of 13.49M SEK with 55.93% growth. Biovica International AB had revenue of 4.92M in the quarter ending April 30, 2026, with 108.39% growth.

Revenue
13.49M
Revenue Growth
+55.93%
P/S Ratio
7.79
Revenue / Employee
539.40K
Employees
25
Market Cap
105.09M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Apr 30, 202613.49M4.84M55.93%
Apr 30, 20258.65M1.35M18.55%
Apr 30, 20247.30M2.08M39.99%
Apr 30, 20235.21M113.00K2.22%
Apr 30, 20225.10M-2.38M-31.84%
Apr 30, 2021 Pro Pro Pro
Apr 30, 2020 Pro Pro Pro
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
IRLAB Therapeutics AB92.46M
Alzinova AB25.66M
Scandinavian ChemoTech AB12.61M
AcouSort AB10.05M
NextCell Pharma AB9.24M
Spago Nanomedical AB4.38M
Simris Group AB (PUBL)1.88M
Alligator Bioscience AB520.00K
Revenue Rankings

Biovica International AB News

More News